SR. VP, GENERAL COUNSEL & SEC.
Fri, Sep 12, 2025
Sep 12
400 shares @ $98.42
Decreased holdings by -0.50%
15th largest trade (out of 49)
Trade made by an officer
10b5-1 scheduled trade
41% win rate · +5.0% median edge vs SPY (22 trades, 90-day)
Price 48% above 200-day moving average
ANIPANI PHARMACEUTICALS INC
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W-4.98%
1M-2.11%
3M+3.18%
6M—
1Y—